• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human CPXM2 Polyclonal Antibody

The antibody against CPXM2 was raised in rabbit using the Human CPXM2-Specific as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB.

ADC-46618A

The antibody against CPXM2 was raised in rabbit using the Human CPXM2-Specific as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB.

$600.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-46618A ClonalityPolyclonal
Host SpeciesRabbitTarget NameCPXM2
Target SynonymsCPXM2 antibody; CPX2 antibody; UNQ676/PRO1310Inactive carboxypeptidase-like protein X2 antibodyFormLiquid
Species ReactivityHumanIsotypeIgG
Storage Buffer50% Glycerol, Avoid freeze / thaw cycles., PBS with 0.1% Sodium AzidePurification MethodAntigen affinity purified
ConjugateNon-conjugatedApplicationELISA, WB
StorageUpon receipt

Immunogen Information


Immunogen DescriptionHuman CPXM2-SpecificTarget SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ8N436
Background Information
  • Uniprot Id

    Q8N436

  • Target Species

    Human

  • Target Name

    CPXM2

  • Target Full Name

    Inactive carboxypeptidase-like protein X2

  • Target Function

    May be involved in cell-cell interactions.

  • Target Subcellular Location

    Secreted.

  • Target Protein Families

    Peptidase M14 family

  • Target Synonyms

    CPXM2; CPX2; UNQ676/PRO1310Inactive carboxypeptidase-like protein X2

Inquire Rabbit anti-Human CPXM2 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification